Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm
NCT00871065
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
PI decision
Conditions
Cerebral Vasospasm
Subarachnoid Hemorrhage
Interventions
DRUG:
Sildenafil citrate
Sponsor
University of Nebraska